Widespread disparities exist in treating advanced kidney and bladder cancers

A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers. The findings, published in Urologic Oncology: Seminars and Original Investigations, suggest that factors such as race, socioeconomic status, and the type of health care facility influence whether patients will receive these effective therapies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup